Vaccines Available in the United States
Vaccine | Type | Route |
|---|---|---|
Anthrax vaccine (seeCDC) | Inactivated bacteria | Subcutaneous |
Bacille Calmette-Guérin vaccine fortuberculosis (see CDC) | Live Mycobacteria bovis | Intradermal or subcutaneous |
Chikungunya vaccine (seeCDC) | Live-attenuated vaccine | IM |
Cholera vaccine (seeCDC) | Live-attenuated vaccine | Oral |
SARS-CoV-2 virus (COVID-19) mRNA vaccine (seeCDC) | Viral mRNA (produced by Moderna and Pfizer-BioNTech) | IM |
SARS-CoV-2 virus (COVID-19) adenovirus vector vaccine (seeCDC) | COVID-19 spike protein DNA in an adenovirus 26 vector (produced by Janssen/Johnson & Johnson) | IM |
SARS-CoV-2 virus (COVID-19) recombinant spike protein nanoparticle vaccine (seeCDC) | Adjuvanted containing a recombinant form of the SARS-CoV-2 spike protein (produced by Novavax) | IM |
Dengue tetravalent vaccine (seeCDC) | Tetravalent, live-attenuated vaccine | Subcutaneous |
Diphtheria toxoid/Haemophilus influenzae type B conjugate vaccine/inactivated poliovirus vaccine (see CDC) | Toxoids, inactivated bacteria, inactivated poliovirus, and bacterial polysaccharide conjugated to protein | IM |
Diphtheria toxoid/hepatitis B vaccine/inactivated poliovirus vaccine (seeCDC) | Toxoids, recombinant viral antigen, and inactivated poliovirus | IM |
Diphtheria toxoid/inactivated poliovirus vaccine (seeCDC) | Toxoids, inactivated bacteria, and inactivated poliovirus | IM |
Diphtheria/tetanus toxoids/pertussis vaccine (seeCDC) | Toxoids and inactivated bacterial components | IM |
Diphtheria toxoid/tetanus toxoid adsorbed, DT, Td (seeCDC)‡ | Inactivated toxins (toxoids) | IM† |
Ebola (rVSV-ZEBOV) (see CDC) | Live-attenuated recombinant vaccine (protects against only the Zaire ebolavirus species) | IM |
Haemophilus influenzae type b conjugate vaccine (see CDC) | Bacterial polysaccharide conjugated to protein | IM |
Hepatitis A vaccine (seeCDC) | Inactivated virus | IM |
Hepatitis B vaccine (seeCDC) | Recombinant viral antigen | IM |
Hepatitis A vaccine/hepatitis B vaccine | Inactivated virus plus recombinant viral antigens | IM |
Human papillomavirus 9-valent vaccine (seeCDC) | Noninfectious viruslike particles | IM |
Intranasal influenza vaccine (seeCDC) | Live influenza A and B virus | Intranasal |
Influenza, types A and B (inactivated) | Inactivated virus or viral components | IM or intradermal |
Japanese encephalitis virus vaccine (seeCDC) | Inactivated virus | Subcutaneous |
Measles/mumps/rubella vaccines (seeCDC) | Live viruses | Subcutaneous |
Measles virus/mumps virus/rubella virus/varicella virus vaccine (seeCDC) | Live viruses | Subcutaneous |
Meningococcal conjugate vaccine (MenACWY) (see CDC) | Bacterial polysaccharides of serogroups A, C, Y, and W-135 conjugated to diphtheria toxoid protein | IM |
Meningococcal conjugate vaccine (5 strain: A, B, C, W, Y) (see CDC) | Serogroups A, C, W, and Y polysaccharides individually conjugated to TT, AND 2 recombinant lipidated factor H binding protein (fHbp) serogroup B variants | IM |
Meningococcal group B vaccine (4 strain) and meningococcal group B vaccine (3 strain) (seeCDC) | Recombinant vaccines composed of two antigens (factor H–binding proteins) | IM |
Mpox (monkeypox)(smallpox and monkeypox vaccine, live, nonreplicating) | Live vaccinia virus | Subcutaneous, or intradermal via multiple puncture device |
Pneumococcal vaccine, polysaccharide (PPSV23) (seeCDC) | Bacterial polysaccharides of 23 pneumococcal types | IM or subcutaneous |
Pneumococcal vaccine, conjugate (PCV15) (seeCDC) | Polysaccharides of 15 types, conjugated to diphtheria toxin | IM |
Pneumococcal vaccine, conjugate (PCV20) (seeCDC) | Polysaccharides of 20 types, conjugated to diphtheria toxin | IM |
Pneumococcal 21-valent conjugate (PCV21) (see CDC) | Polysaccharides of 21 types, conjugated to diphtheria toxin | IM |
Poliovirus vaccine, inactivated, IPV (seeCDC) | Inactivated viruses of all 3 serotypes | IM |
Rabies vaccine (seeCDC) | Inactivated virus | Intradermal* or subcutaneous |
Respiratory syncytial virus (RSV) vaccine (see CDC) | Recombinant viral glycoprotein antigen | IM |
Rotavirus vaccine (seeCDC) | Live virus | Oral |
Smallpox vaccine (seeCDC) | Live vaccinia virus | Intradermal via multiple puncture device |
Tetanus toxoid (see CDC) | Inactivated toxin (toxoid) | IM† |
Tick-borne encephalitis vaccine (seeCDC) | Inactivated virus | IM |
Tuberculosis (see Bacille Calmette-Guérin above) | — | — |
Typhoid vaccine (seeCDC) | Capsular polysaccharide | IM |
Typhoid vaccine (seeCDC) | Live-attenuated vaccine | Oral |
Varicella-zoster virus vaccine (seeCDC) | Live virus | Subcutaneous |
Yellow fever vaccine (seeCDC) | Live virus | Subcutaneous |
Zoster vaccine (seeCDC) | Recombinant, adjuvanted | IM† |
* Intradermal dose is lower and used only for preexposure vaccination. | ||
† Preparations with adjuvants should be given IM. | ||
‡ Tetanus-diphtheria contains the same amount of tetanus toxoid as diphtheria-tetanus-pertussis or diphtheria-tetanus but a reduced dose of diphtheria toxoid. | ||
CDC = Centers for Disease Control and Prevention; IM = intramuscular; TT = tetanus toxoid. | ||
Modified from the Vaccine Recommendations of the Advisory Committee for Immunization Practices (ACIP). Accessed April 2024. | ||